Amesite Executes Trading Partner Agreement Enabling Secure Connectivity with Leading Homecare Technology Platform

Rhea-AI Summary

Amesite (Nasdaq: AMST) signed an Electronic Transactions Trading Partner Agreement enabling HIPAA-compliant connectivity between its NurseMagic™ EMR and a leading homecare technology platform that processes tens of billions in annual homecare billings. The integration supports standardized EVV transactions mandated by CMS and 21st Century Cures Act, letting providers transmit and receive EVV through existing infrastructure while using NurseMagic™’s AI workflows. Amesite also reported strong recent revenue growth: 69% QoQ in Q2 2026 and 63% growth after launching a census-based Enterprise subscription model.

Positive

• Trading partner agreement with platform processing tens of billions annually
• HIPAA-compliant EVV connectivity to standardized CMS formats
• Revenue +69% QoQ in Q2 2026
• Revenue +63% after Enterprise subscription launch

Negative

• None.

News Market Reaction – AMST

+6.36% 2.0x vol

4 alerts

+6.36% News Effect

+8.3% Peak Tracked

+$536K Valuation Impact

$8.96M Market Cap

2.0x Rel. Volume

On the day this news was published, AMST gained 6.36%, reflecting a notable positive market reaction. Argus tracked a peak move of +8.3% during that session. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $536K to the company's valuation, bringing the market cap to $8.96M at that time. Trading volume was elevated at 2.0x the daily average, suggesting notable buying interest.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Non-acute care market size: $1.55 trillion Q2 2026 revenue growth: 69% QoQ Enterprise model growth: 63% revenue growth +1 more

4 metrics

Non-acute care market size $1.55 trillion Market spanning skilled nursing, home care, senior living and related areas

Q2 2026 revenue growth 69% QoQ Previously announced quarterly revenue increase referenced in release

Enterprise model growth 63% revenue growth After launch of census-based Enterprise subscription model

Prior quarterly revenue increase 140% Previously announced quarterly revenue increase before current milestones

Market Reality Check

Price: $1.8500 Vol: Volume 34,858 vs 28,701 2...

normal vol

$1.8500 Last Close

Volume Volume 34,858 vs 28,701 20-day average (relative volume 1.21x). normal

Technical Price 1.73, trading below 200-day MA at 2.61 and 63.81% below 52-week high.

Peers on Argus

The stock was down 4.42% with at least two peers (e.g., NXPL, LGCL) also declini...

1 Up 2 Down

The stock was down 4.42% with at least two peers (e.g., NXPL, LGCL) also declining (scanner median about -7.3%), while one peer in momentum was up, indicating mixed but broadly negative sector action.

Historical Context

3 past events · Latest: Mar 04 (Positive)

Pattern 3 events

Date	Event	Sentiment	Move	Catalyst
Mar 04	Award recognition	Positive	-6.2%	NurseMagic™ named award finalist with detailed staged revenue acceleration.
Dec 19	Product launch	Positive	+17.2%	Launch of AI-native NurseMagic EMR and strong multi-quarter revenue growth.
Oct 30	Earnings and outlook	Positive	-0.8%	Reported 69% QoQ revenue increase and expanding AI product roadmap.

Pattern Detected

Recent positive AI and growth updates have produced mixed reactions, with two of three upbeat releases followed by share price declines.

Recent Company History

Over the last few months, Amesite has repeatedly highlighted rapid growth and AI-focused product expansion. On Oct 30, 2025, it reported a 69% QoQ revenue increase and plans for an AI-powered EMR, but the stock slipped slightly. The Dec 19, 2025 launch of the AI-native NurseMagic EMR into a large post-acute market drove a 17.18% gain. A Mar 4, 2026 award finalist announcement with staged revenue acceleration then saw a -6.21% move, showing inconsistent alignment between positive news and price.

Market Pulse Summary

The stock moved +6.4% in the session following this news. A strong positive reaction aligns with the...

Analysis

The stock moved +6.4% in the session following this news. A strong positive reaction aligns with the company’s strategy of integrating NurseMagic™ into existing homecare infrastructure while operating in a roughly $1.55 trillion non-acute market. Past news saw mixed follow-through, with one major AI EMR launch leading to a 17.18% gain but other upbeat updates selling off. Investors would likely weigh rapid growth figures such as 69% and 140% quarterly increases against ongoing losses and financing needs disclosed in recent filings.

Key Terms

hipaa, electronic visit verification (evv), centers for medicare & medicaid services (cms), 21st century cures act, +1 more

5 terms

hipaa regulatory

"The Agreement establishes Amesite as a compliant trading partner, in accordance with HIPAA and applicable regulations."

A U.S. law that sets rules for keeping individuals’ health information private and secure, and for how that information can be shared. Think of it as a mandatory lock-and-key system for medical records that hospitals, insurers, and tech vendors must use. Investors care because failing to follow these rules can lead to big fines, costly remediation, loss of business access to patient data, and reputational damage that can hurt a company’s finances and growth prospects.

electronic visit verification (evv) regulatory

"This integration allows NurseMagic™ to streamline critical electronic visit verification (EVV) by leveraging standardized formats..."

A system that records and confirms in-home or remote healthcare visits by capturing who provided the care, when and where it happened, and what services were delivered, often using GPS, timestamps, and electronic signatures. For investors, EVV matters because it affects whether providers get paid, reduces billing errors and fraud risk, and can drive demand for software and devices — think of it as a GPS-enabled time card that protects revenue and compliance.

centers for medicare & medicaid services (cms) regulatory

"...leveraging standardized formats mandated by Centers for Medicare & Medicaid Services (CMS) and the 21st Century Cures Act..."

A federal agency that runs the United States' major public health insurance programs for older adults, people with disabilities, and low-income individuals. Investors watch its rules, reimbursement rates and coverage decisions because they directly affect the revenue and costs of healthcare providers, drug makers and medical device companies—like a referee whose calls change how the game is played and who scores.

21st century cures act regulatory

"...mandated by Centers for Medicare & Medicaid Services (CMS) and the 21st Century Cures Act, widely used by homecare providers..."

A federal law that changed how medical treatments, devices and health research are regulated and funded, aiming to speed development and approval while expanding use of real‑world data and patient-focused evidence. For investors, it matters because it can shorten the time and cost needed for products to reach market, change evidentiary standards and funding flows, and therefore affect the commercial prospects, valuation and risk profile of companies in health care and biotech.

emr medical

"...including the launch of its AI‑native NurseMagic™ EMR for non‑acute care, a 69% QoQ revenue increase in Q2 2026..."

An electronic medical record (EMR) is a digital version of a patient’s paper chart used by a single clinic or hospital to store medical history, test results, prescriptions and treatment notes. For investors, EMR systems matter because they drive recurring software and service revenue, affect healthcare providers’ costs and efficiency, and carry regulatory, privacy and interoperability risks that can influence adoption, contract value and long‑term market growth.

AI-generated analysis. Not financial advice.

Agreement Enables HIPAA-Compliant Exchange of EVV Transactions with Company Processing Billions of Dollars in Homecare Services Billed Annually

DETROIT, March 26, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into an Electronic Transactions Trading Partner Agreement with a leading homecare technology platform company, that processes tens of billions of dollars in homecare services annually. The Agreement establishes Amesite as a compliant trading partner, in accordance with HIPAA and applicable regulations.

Under the Agreement, Amesite is authorized to securely connect NurseMagic™ to a leading electronic transaction infrastructure as a healthcare data submitter. This integration allows NurseMagic™ to streamline critical electronic visit verification (EVV) by leveraging standardized formats mandated by Centers for Medicare & Medicaid Services (CMS) and the 21^st Century Cures Act, widely used by homecare providers nationwide. Furthermore, the Agreement enables NurseMagic™ to transmit and receive these transactions for providers, allowing organizations using the larger homecare technology platform to integrate NurseMagic™’s AI-powered workflows into their daily operations without changing the way that their EVV compliance function works.

Amesite CEO Dr. Ann Marie Sastry said, “We believe we are the first company to deliver an AI-first EMR solution for non-acute care: a major advancement in a roughly $1.55 trillion market spanning skilled nursing, home care, home health, senior living, hospice and private pay. This integration is important evidence that our disciplined, infrastructure-first approach is working. Our customers can integrate mandated technologies like EVV through the familiar channels they already use, with NurseMagic™’s AI-first infrastructure—that performs like moving from DSL to gigspeed fiber without changing your router. NurseMagic™ delivers a radically simplified, AI-first workspace, with single-source-of-truth records and workflows organized for machines as well as people, enabling transformative AI to entire businesses seamlessly, compliantly and at scale.”

Amesite Senior AI Manager, Sai Nittala said, “EVV is an example of a regulatory function already managed by scaled, incumbent platforms whose compliance infrastructure we can leverage to mutual benefit. As an innovator in healthcare AI, we take on the most complex parts of care workflows, turning information no human can realistically integrate at scale into clear, usable documentation through our AI infrastructure. By connecting NurseMagic™ into the systems agencies already rely on for CMS compliance, we enable standard interfaces to handle routine processes while our native AI capabilities focus on transforming the quality, speed, and efficiency of the work itself.”

The market’s positive signals to NurseMagic™’s innovative platform are exemplified by NurseMagic™ being named a finalist for Nurse.org’s “Best of Nursing: AI Nursing Tool” award and recognition of Amesite’s CEO as a Commercial Excellence Honoree by McKnight’s. Customer testimonials praise multiple dimensions of the platform, including how it is a “must-have” to stay competitive, enables them to handle more medically complex clients, saves money and time, and creates documentation that complies with CMS review.

This announcement follows a series of milestones for Amesite, including the launch of its AI‑native NurseMagic™ EMR for non‑acute care, a 69% QoQ revenue increase in Q2 2026, and a 63% revenue growth following the launch of its census-based Enterprise subscription model. These milestones build on previously announced quarterly revenue increase of 140%, expanded enterprise offerings due to customer demand, and full HIPAA compliance, positioning Amesite to pursue significant opportunities in the non‑acute care markets.

About Amesite Inc.

Amesite (NASDAQ: AMST) is an AI-driven software company focused on delivering technology platform solutions. Its flagship product, NurseMagic™, is designed to streamline clinical documentation, support point-of-care decision-making, and deliver actionable operational insight, and has expanded from an assistant for individual clinicians into an enterprise platform that includes an electronic medical record (EMR) offering. NurseMagic™ is used by used by over 130 professions across all 50 states and over 20 countries. Built on proprietary AI and designed to meet applicable regulatory and security requirements, the platform serves B2B and B2C users with capabilities that include workflow integration and multilingual support.

Forward-Looking Statements

This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Sources

1. https://www.grandviewresearch.com/industry-analysis/us-skilled-nursing-facility-market
2. https://www.ibisworld.com/united-states/industry/home-care-providers/1579/
3. https://www.grandviewresearch.com/industry-analysis/us-home-healthcare-market-report
4. https://www.grandviewresearch.com/industry-analysis/us-senior-living-market-report
5. https://www.grandviewresearch.com/industry-analysis/us-hospice-market
6. https://www.aaltci.org/news/long-term-care-insurance-news/out-of-pocket-expenditures-for-nursing-home-care-expenditures-to-grow

FAQ

What does the Amesite (AMST) trading partner agreement announced March 26, 2026 do?

It authorizes NurseMagic™ to securely connect as a HIPAA-compliant data submitter for EVV transactions. According to the company, this enables standardized CMS-format EVV transmission and receipt through a large homecare platform providers already use.

How will the AMST integration affect EVV compliance for NurseMagic™ customers?

It preserves existing EVV compliance channels while adding NurseMagic™ AI workflows. According to the company, providers can maintain familiar EVV processes while benefiting from AI-powered documentation and workflow integration.

What revenue growth did Amesite (AMST) report around this announcement?

Amesite reported 69% quarter-over-quarter revenue growth in Q2 2026. According to the company, this followed a 63% revenue increase after launching its census-based Enterprise subscription model.

Which regulatory standards does the AMST agreement support for electronic visit verification?

The agreement supports EVV formats mandated by CMS and the 21st Century Cures Act. According to the company, NurseMagic™ will transmit and receive standardized EVV transactions to meet those regulatory requirements.

Does the AMST agreement require providers to change their current EVV systems?

No; providers can keep existing EVV channels while integrating NurseMagic™ AI workflows. According to the company, the integration works through familiar interfaces so compliance functions remain unchanged.

What scale of partner did Amesite (AMST) connect with in this agreement?

The partner processes tens of billions of dollars in homecare services annually. According to the company, that scale allows NurseMagic™ to reach providers already using the partner’s transaction infrastructure.